This compound is a pharmaceutical reference standard intermediate, characterized as a pyridine-carboxamide derivative bearing chloro, trifluoromethyl, and ether-linked aromatic substructures. It is used in analytical and manufacturing quality control processes within the pharmaceutical supply chain.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1431697-81-2
Sorafenib
n.a
Sorafenib tosylate
active pharmaceutical ingredient
1-Chlorocarbonyl-4-piperidinopiperidine hydrochloride
Pharmaceutical intermediate for synthesis
(3R,5R)-3-Amino-5-hydroxy-piperidine-1-carboxylic acid tert-butyl ester
Pharmaceutical intermediate
5-bromo-3-[[(2R)-1-methyl-2-pyrrolidinyl]methyl]-1H-Indole
Pharmaceutical intermediate for APIs
Fmoc-D-Aph(tBuCbm)-OH
Pharmaceutical intermediate for peptide synthesis
Regorafenib
active pharmaceutical ingredient
Regorafenib monohydrate
active pharmaceutical ingredient
4-[4-[[2-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
JWAKXXCHFJSKRN-UHFFFAOYSA-N
CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC=CC(=C3Cl)C(F)(F)F